American Herbal Products Association (AHPA) > Bookstore > Seminars

Webinar: Compliance with FDA’s Revised Nutrition Labeling Regulations

Nutrition labeling requirements for foods and supplements scheduled to take effect January 1, 2020

Nutrition labeling requirements for foods and dietary supplements are scheduled to take effect January 1, 2020 for manufacturers with $10 million or more in annual sales and January 1, 2021 for smaller manufacturers.

Webinar: Adverse Event Reports (AERs) and Recalls of Dietary Supplements

In-depth review of AER requirements and recent AER and recall data and trends

Dr. Rick Kingston, an industry expert with more than 35-years of experience, presents on serious adverse event report (SAER) data and observations. Ashish Talati, a partner with Amin Talati & Wasserman and one of the industry’s foremost experts on FDA regulatory matters, joins Dr. Kingston to review dietary supplement legal and regulatory SAER obligations. In addition, AHPA Chief Information Officer Dr. Merle Zimmermann presents an overview of recent FDA recall data.

Revised Hemp-CBD Status Report

How hemp and CBD companies are impacted by passage of the Farm Bill

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

Free GRMA webinar on new ANSI-accredited auditing standards

Free GRMA webinar on new ANSI-accredited auditing standards

Webinar recording and handouts

AHPA partnered with the Global Retailer and Manufacturer Alliance (GRMA) to present this free webinar on February 26, 2019 to provide the herbal industry with specific details on the benefits and implementation costs of the new GRMA ANSI-accredited auditing standards.

FDA Inspection Trends, cGMP Compliance Issues and Responding to an FDA 483

Two-part webinar recorded Dec. 4 and 18

Two-part webinar will provide data on recent FDA inspections, an overview of emerging compliance issues and strategies for responding to an FDA 483 in order to avoid an FDA warning letter.

How to Submit an NDI Notification Without Objection

Attendees receive complementary access to AHPA's NDI Database

Attend this webinar to learn how to successfully traverse the NDI notification process and avoid common pitfalls that can result in FDA objections.

CA Prop 65 Update on Regulatory, Compliance and Litigation Developments

An overview of several significant developments related to Prop 65

Recorded September 20, 2018 -- Duration: 2 hours

Claims substantiation webinar

Ensure supplement claims are truthful, legal, substantiated, and will help maximize your marketing

Recorded Aug. 21, 2018 -- Member cost: $199. Nonmember cost: $399.

A Primer on AHPA’s Good Agricultural and Collection Practices and Good Manufacturing Practices (GACP-GMP) Guidance for Botanical Materials

What is AHPA's GACP-GMP guidance and how can it help your business?

Recorded May 22, 2018 -- Member cost: $150. Nonmember cost: $350.

FDA Inspection Trends, cGMP Compliance Issues and Responding to an FDA 483

Recorded Nov. 30 and Dec. 14

This two-part webinar provides an update on the elements of current Good Manufacturing Practice (cGMP) regulations (21 CFR 111) that have been the primary focus of recent FDA inspections. Experts also provide strategies to respond to an FDA  483 in order to avoid a warning letter.

RSS
12345

2019 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.